drug

VS-7375

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 3 registered trials in coverage

Relationships

Developed by Verastem, Inc.

Timeline

Verastem starts dosing in all three VS-7375 registration trials, secures added $75M financing

Aug 6Quarterly updateVerastem, Inc.VS-7375

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.